Boston Scientific has exercised its option to wholly acquire Millipede, having purchased a $90m stake in the mitral regurgitation treatment device maker last year.

Medical device manufacturer Boston Scientific has acquired the rest of the shares in one of its portfolio companies, US-based mitral regurgitation system developer Millipede Medical, for $325m. The transaction is expected to close within the first quarter of this year. Millipede will receive an additional $125m payment if it reaches an unspecified commercial milestone. Founded…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.